FXR agonists increase liver-derived serum alkaline phosphatase by species-specific pharmacologic mechanisms independent of cholestasis

被引：0

作者：

Schumacher, Justin ^{[1
]}

Su, Ting ^{[1
]}

Azzara, Anthony ^{[1
]}

Bhaskaran, Vasanthi ^{[1
]}

Cao, Gary ^{[1
]}

Ziegler, Milinda ^{[1
]}

Burns, Lisa ^{[1
]}

Kong, Bo ^{[2
]}

Guo, Grace ^{[2
]}

Chadwick, Kristina ^{[3
]}

Krupinski, John ^{[1
]}

Janovitz, Evan ^{[1
]}

机构：

[1] Bristol Myers Squibb, Nonclin Res & Dev, Princeton, NJ USA

[2] Rutgers State Univ, Dept Pharmacol & Toxicol, New Brunswick, NJ USA

[3] Bristol Myers Squibb, Global Regulatory Strategy & Policy, Princeton, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PO-1606

引用

页码：S529 / S530

页数：2

共 2 条